Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07376005 · ClinicalTrials.gov registry record · NA
Effects of Acute Sugar Intake on Choroidal Thickness
A NA study of Choroid, sponsored by Southern College of Optometry.
- Recruiting
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT07376005: Recruiting NA study of Choroid, sponsored by Southern College of Optometry.
NCT07376005 is a NA study of Choroid that is actively recruiting participants, run by Southern College of Optometry. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07376005, a NA study of Choroid, is actively recruiting participants, sponsored by Southern College of Optometry.
- RECRUITING
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to bridge that gap by investigating how acute sugar intake influences choroidal thickness.
Primary Outcome
The primary outcome for this investigation will be changes in choroidal thickness from baseline across timepoints.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Oral glucose
Study Locations (1)
Tennessee
- Southern College of Optometry - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2026-01 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT07376005 shows while recruiting
NCT07376005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Choroid appearing as the primary indexed condition, and to 1 intervention - of which Oral glucose is the first listed.
NCT07376005 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT07376005 about?
NCT07376005 is a clinical study titled "Effects of Acute Sugar Intake on Choroidal Thickness". This study aims to bridge that gap by investigating how acute sugar intake influences choroidal thickness.
What is the current status of trial NCT07376005?
This trial is currently recruiting. It is a NA study. The enrollment target is 47 participants. The study started on 2026-01. Estimated completion is 2026-05.
What conditions does trial NCT07376005 study?
This clinical trial studies the following conditions: Choroid.
What interventions are being tested in trial NCT07376005?
The interventions under investigation include: Oral glucose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07376005?
This trial is sponsored by Southern College of Optometry, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07376005 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07376005's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia